Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 60 (1), 71-84
- https://doi.org/10.1194/jlr.m087189
Abstract
No abstract availableKeywords
Funding Information
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (K08 HL124068)
- National Institutes of Health (LRP HMOT1243)
- Hellman Foundation
- Pfizer Foundation
This publication has 65 references indexed in Scilit:
- SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretioneLife, 2013
- Clinical implications of discordance between low-density lipoprotein cholesterol and particle numberJournal of Clinical Lipidology, 2011
- A Two-step Binding Model of PCSK9 Interaction with the Low Density Lipoprotein ReceptorOnline Journal of Public Health Informatics, 2011
- Effects of the Prosegment and pH on the Activity of PCSK9Online Journal of Public Health Informatics, 2010
- Molecular basis for LDL receptor recognition by PCSK9Proceedings of the National Academy of Sciences of the United States of America, 2008
- Self-Association of Human PCSK9 Correlates with Its LDLR-Degrading ActivityBiochemistry, 2008
- The self-inhibited structure of full-length PCSK9 at 1.9 Å reveals structural homology with resistin within the C-terminal domainProceedings of the National Academy of Sciences of the United States of America, 2007
- Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotypeProceedings of the National Academy of Sciences of the United States of America, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiationProceedings of the National Academy of Sciences of the United States of America, 2003